logo
Select company
Select metric
0.1Current Ratio
VS
Market
2
Sector
1
Industry
1
History
-
$ 2.58Close
$ 2.36 - $ 27 52-Week Range
Ticker Information

Ticker

AIM

Company Name

AIM IMMUNOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

AIM IMMUNOTECH INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIM - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 1.02M0.1$ 10.39M
3/31/2025$ 2.58M0.26$ 9.77M
12/31/2024$ 4.18M0.44$ 9.54M
9/30/2024$ 7.57M0.75$ 10.1M
6/30/2024$ 10.36M1.17$ 8.84M
3/31/2024$ 11.31M1.14$ 9.88M
12/31/2023$ 14.56M1.68$ 8.65M
9/30/2023$ 22.74M4.82$ 4.72M
6/30/2023$ 28.87M10.01$ 2.88M
3/31/2023$ 33.16M18.05$ 1.84M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AIM IMMUNOTECH INC's latest trailing twelve months (TTM) Current Ratio stands at 50.01.
  • Over the past 5 years, AIM IMMUNOTECH INC's average Current Ratio has been 24.48.
  • The median Current Ratio for AIM IMMUNOTECH INC during this period was 16.13
  • AIM IMMUNOTECH INC reached its highest Current Ratio over the past 5 years at 74.61.
  • The lowest Current Ratio recorded by AIM IMMUNOTECH INC in the same timeframe 0.1

AIM IMMUNOTECH INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
SILO : SILO PHARMA INC 6.07VIVS : VIVOSIM LABS INC 4.52HCWB : HCW BIOLOGICS INC 0.11CDIO : CARDIO DIAGNOSTICS HOLDINGS INC 23.55IBO : IMPACT BIOMEDICAL INC 0.06PMCB : PHARMACYTE BIOTECH INC 18.01APVO : APTEVO THERAPEUTICS INC 2.27ACXP : ACURX PHARMACEUTICALS INC 2.38PALI : PALISADE BIO INC 1.62GNPX : GENPREX INC 0.84

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for AIM IMMUNOTECH INC is calculated as follows: AssetsC [ $ 39.76M ] / LiabilitesC [ $ 795K ]
(=) Current Ratio [ 50.01 ]

AIM - Current Ratio, Last 5 years

0.1

Minimum

Jun 30, 2025

74.61

Maximum

Dec 31, 2021

24.48

Average

16.13

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44